Company overview

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.
Founded in 1987
Luxembourg, Luxembourg, LUX
26K employees
49% recommend to a friend
43% positive business outlook

Salaries

Help build salary transparency at Eurofins

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

20 open now

Headcount trend

Company growth over the last 12 months

Headcount +3.1% year over year

Funding

Total funding

$1B

Last raise

$584.6M

Post IPO Debt, 9 months ago

Funding history

Jun 2025

Post IPO Debt Eurofins · $584.6M

Mar 2025

Post IPO Debt Eurofins · $432M

Oct 2021

Grant Eurofins · $30M

Audience

Monthly website visitors
561.8K
Month over month-12.2%
Quarter over quarter-4.7%
Top sourceSearch (43.7%)
Ad budget per month$7.7K
Average search rank54.3
Traffic source mix
Search
43.7%
Direct
41.1%
Referral
12.1%
Social
1.8%
Paid referral
1.1%

LinkedIn followers

Follower count and growth

Total followers

786.1K

12-mo growth

+56.2%

Monthly growth

+4%

News

Links